Guillain-Barré syndrome — IVIG vs plasma exchange, criteria for ICU admission and intubation?

1 Answer

**Treatment Equivalence (IVIG vs. PEX):** According to the EFNS/PNS (European Federation of Neurological Societies/Peripheral Nerve Society) and AAN (American Academy of Neurology) guidelines, both Intravenous Immunoglobulin (IVIG) and Plasma Exchange (PEX) are established, effective, and equivalent first-line treatments for Guillain-Barré Syndrome (GBS). The choice often depends on availability, patient comorbidities (e.g., renal failure favors PEX; IgA deficiency or congestive heart failure favors PEX), and ease of administration (IVIG is generally easier to administer in most centers). **ICU Admission & Respiratory Monitoring:** The patient should be admitted to the Intensive Care Unit (ICU) immediately. An Forced Vital Capacity (FVC) of 28% predicted indicates significant respiratory muscle weakness and a high risk of impending respiratory failure. Additionally, the presence of autonomic instability (fluctuating heart rates of 38-140) mandates continuous cardiac monitoring in an ICU setting due to the risk of life-threatening arrhythmias or sudden cardiac arrest. **Indications for Intubation:** The "20-30-40 rule" is a widely recognized clinical tool for monitoring respiratory status in GBS: - **FVC < 20 mL/kg** (or <30% of predicted) - **Maximal Inspiratory Pressure (MIP) < -30 cmH2O** - **Maximal Expiratory Pressure (MEP) < 40 cmH2O** Elective intubation is generally recommended when the FVC drops below 20 mL/kg (or 30% predicted) or if there is clinical evidence of respiratory distress, poor cough, or inability to clear secretions, rather than waiting for arterial blood gas abnormalities (which are late signs). *This discussion is for peer-to-peer educational purposes and is not a substitute for formal clinical judgment.*